HBB and acute myeloid leukemia: No difference in mtDNAc was observed among the cytogenetically defined AML subgroups in both cohorts, also not in patients with cytogenetic alterations involving chromosomes 1 and 11, where PKLR and HBB genes are located, that were used as genomic DNA internal controls (Fig. 1a and supplementary Fig. 1b).